This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1 Y Seto , A Kimura , Y Akai , et al. (2003) Distribution of the Lactobacillus acidophilus complex in human fecal specimens examined by restriction fragment length polymorphism of the 16S rRNA genes. Biosci Microflora 22, 75–83.
2 H Takahashi , T Fujita , Y Suzuki , et al. (2006) Monitoring and survival of Lactobacillus gasseri SBT2055 in the human intestinal tract. Microbiol Immunol 50, 867–870.
3 S Fujiwara , Y Seto , A Kimura , et al. (2001) Establishment of orally-administered Lactobacillus gasseri SBT2055SR in the gastrointestinal tract of humans and its influence on intestinal microflora and metabolism. J Appl Microbiol 90, 343–352.
4 E Imai , K Fukui , N Ohta , et al. (2002) Effects of Lactobacillus gasseri SBT2055 on dextran sulfate sodium-induced ulcerative colitis model in rats. Biosci Microflora 21, 179–183.
5 Y Kadooka , K Tominari , F Sakai , et al. (2012) Prevention of rotavirus-induced diarrhea by preferential secretion of IgA in breast milk via maternal administration of Lactobacillus gasseri SBT2055. J Pediatr Gastroenterol Nutr 55, 66–71.
6 M Sato , K Uzu , T Yoshida , et al. (2008) Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats. Br J Nutr 99, 1013–1017.
7 Y Kadooka , A Ogawa , K Ikuyama , et al. (2011) The probiotic Lactobacillus gasseri SBT2055 inhibits enlargement of visceral adipocytes and upregulation of serum soluble adhesion molecule (sICAM-1) in rats. Int Dairy J 21, 623–627.
8 Y Kadooka , M Sato , K Imaizumi , et al. (2010) Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr 64, 636–643.
10 ME Sanders (2003) Probiotics: considerations for human health. Nutr Rev 61, 91–99.
11 T Vasiljevic & NP Shah (2008) Probiotics – from Metchnikoff to bioactives. Int Dairy J 18, 714–728.
12 ME Sanders (2008) Probiotics: definition, sources, selection, and uses. Clin Infect Dis 46, S58–S61.
13 R Shigematsu , T Okura , S Kumagai , et al. (2006) Cutoff and target values for intra-abdominal fat area for prevention of metabolic disorders in pre- and post-menopausal obese women before and after weight reduction. Circ J 70, 110–114.
15 K Murakami , S Sasaki & H Okubo (2012) Characteristics of under- and over-reporters of energy intake among young Japanese women. J Nutr Sci Vitaminol (Tokyo) 58, 253–262.
16 RM Buijs & F Kreier (2006) The metabolic syndrome: a brain disease? J Neuroendocrinol 18, 715–716.
17 I Kyrou , GP Chrousos & C Tsigos (2006) Stress, visceral obesity, and metabolic complications. Ann N Y Acad Sci 1083, 77–110.
18 AD Sniderman , R Bhopal , D Prabhakaran , et al. (2007) Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis. Int J Epidemiol 36, 220–225.
21 SL Peach & S Tabaqchali (1984) Some studies of the bacterial flora associated with the mucosa of the human gastrointestinal tract. Nahrung 28, 627–634.
23 S Rakoff-Nahoum , J Paglino , F Eslami-Varzaneh , et al. (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229–241.
24 E Cario (2008) Barrier-protective function of intestinal epithelial Toll-like receptor 2. Mucosal Immunol 1, S62–S66.
25 B Ey , A Eyking , G Gerken , et al. (2009) TLR2 mediates gap junctional intercellular communication through connexin-43 in intestinal epithelial barrier injury. J Biol Chem 284, 22332–22343.
26 J Lee , JH Mo , C Shen , et al. (2007) Toll-like receptor signaling in intestinal epithelial cells contributes to colonic homoeostasis. Curr Opin Gastroenterol 23, 27–31.
27 E Cario , G Gerken & DK Podolsky (2007) Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132, 1359–1374.
28 S Ding , MM Chi , BP Scull , et al. (2010) High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One 5, e12191.
29 S Ding & PK Lund (2011) Role of intestinal inflammation as an early event in obesity and insulin resistance. Curr Opin Clin Nutr Metab Care 14, 328–333.
30 PD Cani , J Amar , MA Iglesias , et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761–1772.
31 DM Tsukumo , MA Carvalho-Filho , JB Carvalheira , et al. (2007) Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56, 1986–1998.
32 T Matsuki , K Watanabe , J Fujimoto , et al. (2004) Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol 70, 7220–7228.
34 L Conterno , F Fava , R Viola , et al. (2011) Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease? Genes Nutr 6, 241–260.
35 MA Hildebrandt , C Hoffmann , SA Sherrill-Mix , et al. (2009) High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137, 1716–1724.
36 MI Queipo-Ortuno , M Boto-Ordonez , M Murri , et al. (2012) Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. Am J Clin Nutr 95, 1323–1334.